Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function

MW Johnson, PS Hendricks, FS Barrett… - Pharmacology & …, 2019 - Elsevier
The purpose of this paper is to provide an integrative review and offer novel insights
regarding human research with classic psychedelics (classic hallucinogens), which are …

Ketamine and depression: a narrative review

A Corriger, G Pickering - Drug design, development and therapy, 2019 - Taylor & Francis
Depression is the third leading cause of disability in the world. Depressive symptoms may
be reduced within several weeks after the start of conventional antidepressants, but …

Targeting glutamate signalling in depression: progress and prospects

JW Murrough, CG Abdallah, SJ Mathew - Nature Reviews Drug …, 2017 - nature.com
Major depressive disorder (MDD) is severely disabling, and current treatments have limited
efficacy. The glutamate N-methyl-d-aspartate receptor (NMDAR) antagonist ketamine was …

Ketamine treatment for depression: a review

M Yavi, H Lee, ID Henter, LT Park, CA Zarate Jr - Discover mental health, 2022 - Springer
This manuscript reviews the clinical evidence regarding single-dose intravenous (IV)
administration of the novel glutamatergic modulator racemic (R, S)-ketamine (hereafter …

Lessons learned from the fate of AstraZeneca's drug pipeline: a five-dimensional framework

D Cook, D Brown, R Alexander, R March… - Nature reviews Drug …, 2014 - nature.com
Maintaining research and development (R&D) productivity at a sustainable level is one of
the main challenges currently facing the pharmaceutical industry. In this article, we discuss …

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial

JW Murrough, DV Iosifescu, LC Chang… - American Journal of …, 2013 - Am Psychiatric Assoc
Objective Ketamine, a glutamate N-methyl-d-aspartate (NMDA) receptor antagonist, has
shown rapid antidepressant effects, but small study groups and inadequate control …

Kynurenines in the mammalian brain: when physiology meets pathology

R Schwarcz, JP Bruno, PJ Muchowski… - Nature Reviews …, 2012 - nature.com
The essential amino acid tryptophan is not only a precursor of serotonin but is also
degraded to several other neuroactive compounds, including kynurenic acid, 3 …

Glutamate receptor ion channels: structure, regulation, and function

SF Traynelis, LP Wollmuth, CJ McBain, FS Menniti… - Pharmacological …, 2010 - ASPET
The mammalian ionotropic glutamate receptor family encodes 18 gene products that
coassemble to form ligand-gated ion channels containing an agonist recognition site, a …

The three-hit concept of vulnerability and resilience: toward understanding adaptation to early-life adversity outcome

NP Daskalakis, RC Bagot, KJ Parker… - …, 2013 - Elsevier
Stressful experiences during early-life can modulate the genetic programming of specific
brain circuits underlying emotional and cognitive aspects of behavioral adaptation to …

The neurobiology of anhedonia and other reward-related deficits

A Der-Avakian, A Markou - Trends in neurosciences, 2012 - cell.com
Anhedonia, or markedly diminished interest or pleasure, is a hallmark symptom of major
depression, schizophrenia and other neuropsychiatric disorders. Over the past three …